ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,211, issued on Aug. 26, was assigned to DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (Daegu, South Korea).
"GFRAL-antagonistic antibody and use thereof" was invented by Kyung Moo Yea (Daegu, South Korea), Beom Yong Lee (Daegu, South Korea) and Jong Won Jeong (Daegu, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a GFRAL-antagonistic antibody and a use thereof, and more particularly, to an anti-GFRAL antibody comprising a heavy chain CDR and a light chain CDR of specific sequences, and an antigen-binding fragment thereof. The anti-GFRAL antibody is expected to be usefully utilized for ameliorating o...